RNS Number : 2146V
Assura PLC
04 July 2024
 

4 July 2024

Assura plc ("Company")

Result of AGM

 

Assura plc announces that at its Annual General Meeting held earlier today, each of the resolutions submitted to the meeting (as set out in the Notice of the Meeting dated 1 June 2024) were passed by the requisite majorities on a poll.

Resolution

For

%

For

Against

% Against

Total Votes Cast (% of issued share capital)

Votes Withheld

1. To receive the Company's report and accounts     

2,504,731,758

99.96

1,068,179

0.04

2,505,799,937 (83.82)

1,786,565

2. To approve the Directors' Remuneration Report     

2,265,917,896

92.18

192,146,274

7.82

2,458,064,170 (82.22)

49,522,332

3. To re-appoint Ernst & Young LLP as auditor of the Company 

2,485,635,180

99.13

21,927,079

0.87

2,507,562,259 (83.88)

24,243

4. To authorise the Audit Committee to determine the auditor's remuneration 

2,507,429,142

99.99

143,591

0.01

2,507,572,733 (83.88)

13,769

5. To re-elect Ed Smith as a Director of the Company

2,334,664,222

93.55

160,936,695

6.45

2,495,600,917 (83.48)

11,985,584

6. To re-elect Louise Fowler as a Director of the Company

2,474,236,435

98.67

33,322,682

1.33

2,507,559,117 (83.88)

27,384

7. To re-elect Jonathan Murphy as a Director of the Company

2,488,262,988

99.23

19,297,044

0.77

2,507,560,032 (83.88)

26,470

8. To re-elect Jayne Cottam as a Director of the Company

2,485,494,253

99.12

22,065,779

0.88

2,507,560,032 (83.88)

26,470

9. To re-elect Jonathan Davies as a Director of the Company

2,456,425,207

98.69

32,559,286

1.31

2,488,984,493 (83.26)

18,602,008

10. To re-elect Sam Barrell as a Director of the Company

2,465,369,797

98.32

42,189,320

1.68

2,507,559,117 (83.88)

27,384

11. To re-elect Emma Cariaga as a Director of the Company

2,506,913,031

99.97

646,087

0.03

2,507,559,118 (83.88)

27,384

12. To re-elect Noel Gordon as a Director of the Company

2,493,543,158

99.44

14,019,160

0.56

2,507,562,318 (83.88)

24,184

13. To authorise the Directors to allot shares

2,389,749,564

95.30

117,821,821

4.70

2,507,571,385 (83.88)

15,117

14. To empower the Directors to disapply pre-emption rights

2,446,423,969

97.60

60,167,285

2.40

2,506,591,254 (83.85)

995,248

15. To empower the Directors to disapply pre-emption rights in connection with an acquisition or specified capital investment

2,326,633,121

93.05

173,780,257

6.95

2,500,413,378 (83.64)

7,173,124

16. To authorise the market purchase of the Company's own shares

2,488,128,029

99.24

19,017,274

0.76

2,507,145,303 (83.87)

441,199

17. To authorise the Company to call any general meeting, other than the Annual General Meeting, by not less than 14 clear days' notice

2,380,425,249

94.93

127,129,789

5.07

2,507,555,038 (83.88)

31,464

18. To amend the Articles of Association with the addition of article 91

2,504,773,882

99.98

417,429

0.02

2,505,191,311 (83.80)

2,395,191

Resolutions 1-13 were passed as ordinary resolutions. Resolutions 14-18 were passed as special resolutions. Votes 'For' include votes at the discretion of the Chairman. 

Notes:

1. The percentages above are rounded to two decimal places.

2. A vote withheld is not a vote in law and is not counted in the calculation of the proportion of votes "for" and "against" a resolution.

3. The number of ordinary shares in issue on the share register at 6.00pm on 3 July 2024 was 2,989,454,390 of which the Total Voting Rights figure was 2,989,454,390.

Copies of resolutions 14-18, being resolutions other than resolutions concerning ordinary business passed by the Company at the above AGM, have been submitted to the National Storage Mechanism and will shortly be available for inspection at https://data.fca.org.uk/#/nsm/nationalstoragemechanism

- Ends -

For more information, please contact:

 

Assura plc

 

Tel: 0161 515 2043

Orla Ball, General Counsel

David Purcell, Investor Relations Director

 

Email: Investor@assura.co.uk

FGS Global

Gordon Simpson
Grace Whelan

Tel: 0207 251 3801

Email: Assura@fgsglobal.com

 

Notes to Editors

Assura plc is the UK's leading specialist healthcare property investor and developer. Assura enables better health outcomes through its portfolio of more than 600 healthcare buildings, from which over six million patients are served.

A UK REIT based in Altrincham, Assura is a constituent of the FTSE 250 and the EPRA* indices. As at 31 March 2024, Assura's portfolio was valued at £2.7 billion and has a strong track record of growing financial returns and dividends for shareholders.

At Assura, we BUILD for health, having developed over 100 new healthcare buildings in our history, and at the heart of our strategy sits The Bigger Picture; Healthy Environment (E), Healthy Communities (S), Healthy Business (G).

Further information is available at www.assuraplc.com

*EPRA is a registered trademark of the European Public Real Estate Association.

Assura plc LEI code: 21380026T19N2Y52XF72

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
RAGSSWFDLELSEDW